Novo Nordisk A/S (TSX:NOVO)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of CAD 292.55 billion. The enterprise value is 315.02 billion.

Market Cap	292.55B
Enterprise Value	315.02B

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.34%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	28.04%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 13.25 and the forward PE ratio is 14.29.

PE Ratio	13.25
Forward PE	14.29
PS Ratio	4.39
PB Ratio	6.99
P/TBV Ratio	21.21
P/FCF Ratio	23.02
P/OCF Ratio	11.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.19, with an EV/FCF ratio of 24.79.

EV / Earnings	14.27
EV / Sales	4.72
EV / EBITDA	9.19
EV / EBIT	10.10
EV / FCF	24.79

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.67.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	0.67
Debt / EBITDA	0.83
Debt / FCF	2.22
Interest Coverage	34.31

Financial Efficiency

Return on equity (ROE) is 60.70% and return on invested capital (ROIC) is 42.22%.

Return on Equity (ROE)	60.70%
Return on Assets (ROA)	17.89%
Return on Invested Capital (ROIC)	42.22%
Return on Capital Employed (ROCE)	44.11%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	963,417
Profits Per Employee	319,308
Employee Count	78,554
Asset Turnover	0.61
Inventory Turnover	1.17

Taxes

In the past 12 months, Novo Nordisk has paid 6.06 billion in taxes.

Income Tax	6.06B
Effective Tax Rate	21.53%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.37
200-Day Moving Average	n/a
Relative Strength Index (RSI)	32.28
Average Volume (20 Days)	19,216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of CAD 66.62 billion and earned 22.08 billion in profits. Earnings per share was 4.96.

Revenue	66.62B
Gross Profit	55.19B
Operating Income	31.11B
Pretax Income	28.14B
Net Income	22.08B
EBITDA	33.85B
EBIT	31.11B
Earnings Per Share (EPS)	4.96

Balance Sheet

The company has 5.81 billion in cash and 28.23 billion in debt, with a net cash position of -22.42 billion.

Cash & Cash Equivalents	5.81B
Total Debt	28.23B
Net Cash	-22.42B
Net Cash Per Share	n/a
Equity (Book Value)	41.83B
Book Value Per Share	9.41
Working Capital	-9.31B

Cash Flow

In the last 12 months, operating cash flow was 25.67 billion and capital expenditures -12.96 billion, giving a free cash flow of 12.71 billion.

Operating Cash Flow	25.67B
Capital Expenditures	-12.96B
Free Cash Flow	12.71B
FCF Per Share	n/a

Margins

Gross margin is 82.85%, with operating and profit margins of 46.70% and 33.14%.

Gross Margin	82.85%
Operating Margin	46.70%
Pretax Margin	42.24%
Profit Margin	33.14%
EBITDA Margin	50.80%
EBIT Margin	46.70%
FCF Margin	19.08%

Dividends & Yields

Novo Nordisk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	50.53%
Buyback Yield	0.34%
Shareholder Yield	0.34%
Earnings Yield	7.55%
FCF Yield	4.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 5.17 and a Piotroski F-Score of 5.

Altman Z-Score	5.17
Piotroski F-Score	5